Continuous Hot-Melt Extrusion for Poorly Soluble APIs: Process control is essential for using continuous hot-melt extrusion to enhance solubility.

Detalles Bibliográficos
Publicado en:Pharmaceutical Technology Europe Vol. 35; no. 5; pp. 18 - 22
Autor principal: Challener, Cynthia A.
Formato: pictorial Journal Article
Publicado: MJH Life Sciences May2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=163834945&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 163834945
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17537967
        5NG
      jtl: Pharmaceutical Technology Europe
      issn: 17537967
      maglogo: N
    pubinfo:
      dt: May2023
      vid: 35
      iid: 5
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        163834945
        163834945
        163834945
        163834945
      ppf: 18
      ppct: 4
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Continuous Hot-Melt Extrusion for Poorly Soluble APIs: Process control is essential for using continuous hot-melt extrusion to enhance solubility.
      aug:
        au: Challener, Cynthia A.
        affil: Contributing editor to Pharmaceutical Technology Europ
      sug:
        subj:
          Pharmaceutical Companies
          Manufacturing Industry
          Solubility
          Technology, Pharmaceutical
          Chemistry, Pharmaceutical
          Biological Availability
          Quality Assurance
      pubtype: Trade Publication
      doctype:
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N